Virios Therapeutics, Inc.
VIRI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $3,317 | $7,031 | $14,008 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $848 | $1,339 | $1,769 |
| Total Curr. Assets | $0 | $4,165 | $8,370 | $15,777 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $0 | $4,165 | $8,370 | $15,777 |
| Liabilities | – | – | – | – |
| Payables | $0 | $112 | $573 | $354 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $247 | $470 | $922 |
| Total Curr. Liab. | $0 | $359 | $1,043 | $1,276 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $573 | $0 |
| Other Liabilities | $0 | $0 | -$573 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $0 | $359 | $1,043 | $1,276 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $2 | $2 | $1 |
| Retained Earnings | $0 | -$61,469 | -$56,173 | -$43,925 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $65,274 | $63,498 | $58,426 |
| Total Equity | $0 | $3,807 | $7,326 | $14,501 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $0 | $4,165 | $8,370 | $15,777 |
| Net Debt | $0 | -$3,317 | -$7,031 | -$14,008 |